{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:09Z","timestamp":1767135249365,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd005526","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T00:00:00Z","timestamp":1184716800000}}],"reference-count":58,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005526.pub2","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T10:37:15Z","timestamp":1183459035000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cyclosporin A for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[{"name":"Bispeberg Bakke 26C, 2.th Copenhagen NV Denmark 2400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Christensen","sequence":"additional","affiliation":[{"name":"Bispebjerg Hospital; Clinic of Internal Medicine I; Bispebjerg Bakke 23 Copenhagen NV Denmark DK-2400"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"10.1002\/14651858.CD005526.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0168-8278(05)80321-6","article-title":"The influence of cyclosporine A therapy on sex hormone levels in pre- and post-menopausal women with primary biliary cirrhosis","volume":"21","author":"Robson","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD005526.pub2-BIB0003|cit3","first-page":"282","article-title":"Parameters of calcium metabolism during a pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis","volume":"14","author":"Hanley","year":"1991","journal-title":"Clinical and Investigative Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(88)90373-3","article-title":"Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis","volume":"95","author":"Minuk","year":"1988","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD005526.pub2-BIB0005|cit5","first-page":"386","article-title":"Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients","volume":"12","author":"Parsons","year":"1989","journal-title":"Clinical and Investigative Medicine"},{"issue":"20","key":"10.1002\/14651858.CD005526.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1034\/j.1600-0676.2001.210505.x","article-title":"Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK 506) as monotherapy induction after orthotopic liver transplantation","volume":"21","author":"Chau","year":"2001","journal-title":"Liver"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00007691-199312000-00010","article-title":"Computer-guided concentration-controlled trials in autoimmune disorders","volume":"15","author":"McMichael","year":"1993","journal-title":"Therapeutic Drug Monitoring"},{"issue":"4","key":"10.1002\/14651858.CD005526.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00007691-199608000-00021","article-title":"Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis","volume":"18","author":"McMichael","year":"1996","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1399-0012.1995.tb00319.x","article-title":"The optimal immunosuppressant after liver transplantation according to diagnosis: Cyclosporine A or FK506?","volume":"9","author":"Mueller","year":"1995","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1089-3261(03)00103-X","article-title":"Primary biliary cirrhosis: specific treatment","volume":"7","author":"Robert","year":"2003","journal-title":"Clinical Liver Disease"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005526.pub2-BIB0014|cit14","first-page":"134","article-title":"Approaches to the treatment of primary biliary cirrhosis - a status report","volume":"3","author":"Slitzky","year":"1990","journal-title":"Gastroenterology International"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD005526.pub2-BIB0015|cit15","first-page":"215","article-title":"Renal function in patients with autoimmune diseases treated with cyclosporine","volume":"17","author":"Graffenried","year":"1985","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-101-5-667","article-title":"Cyclosporine: a new immunosuppressive agent for organ transplantation","volume":"101","author":"Cohen","year":"1984","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005526.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"16","key":"10.1002\/14651858.CD005526.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0020|cit20","first-page":"A1121","article-title":"Antimitochondrial antibodies AMA of primary biliary cirrhosis PBC recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha ketoacid dehydrogenase complex","volume":"3","author":"Fregeau","year":"1989","journal-title":"Faseb Journal"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0021|cit21","unstructured":"Gluud C Nikolova D Klingenberg SL Als-Nielsen B D'Amico G Davidson B Cochrane Hepato-Biliary Group About The Cochrane Collaboration (Cochrane Review Groups (CRGs))"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0022|cit22","unstructured":"Gong Y Frederiksen SL Gluud C D-penicillamine for primary biliary cirrhosis Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0023|cit23","unstructured":"Gong Y Frederiksen SL Gluud C Methotrexate for primary biliary cirrhosis Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1572-0241.2005.41522.x","article-title":"Colchicine for primary biliary cirrhosis: a systematic review of randomised clinical trials","volume":"100","author":"Gong","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0025|cit25","unstructured":"Gong Y Christensen E Gluud C Cyclosporin A for primary biliary cirrhosis (Protocol) Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0008-8749(87)90296-6","article-title":"Mechanism of cyclosporin A induced immunosuppression","volume":"109","author":"Harris","year":"1987","journal-title":"Cell Immunology"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD005526.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0029|cit29","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] The Cochrane Library, Issue 4, 2006 Chichester, UK John Wiley & sons, Ltd"},{"issue":"6","key":"10.1002\/14651858.CD005526.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0031|cit31","volume-title":"Code of Federal Regulation & ICH Guidelines","author":"International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use","year":"1997"},{"issue":"5","key":"10.1002\/14651858.CD005526.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD005526.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","article-title":"Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses","volume":"98","author":"Ioannidis","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8233","key":"10.1002\/14651858.CD005526.pub2-BIB0034|cit34","first-page":"1278","article-title":"Primary biliary cirrhosis - a revised clinical spectrum","volume":"1","author":"James","year":"1981","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-99-4-500","article-title":"Primary biliary cirrhosis: a model autoimmune disease","volume":"99","author":"James","year":"1983","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1002\/14651858.CD005526.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1056\/NEJM199611213352107","article-title":"Primary biliary cirrhosis","volume":"335","author":"Kaplan","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a U.S. community","volume":"119","author":"Kim","year":"2000","journal-title":"Gatroenterology"},{"issue":"11","key":"10.1002\/14651858.CD005526.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005526.pub2-BIB0040|cit40","first-page":"247","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"90","author":"Lacerda","year":"1995","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD005526.pub2-BIB0041|cit41","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0042|cit42","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of National Cancer Institute"},{"issue":"3","key":"10.1002\/14651858.CD005526.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD005526.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"Journal of Hepatology"},{"issue":"9128","key":"10.1002\/14651858.CD005526.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD005526.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD005526.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0049|cit49","unstructured":"Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2003"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(80)92481-2","article-title":"Effects of cyclosporin A on suppressor and induceer T lymphocytes in primary biliary cirrhosis","volume":"2","author":"Routhier","year":"1980","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD005526.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"12","key":"10.1002\/14651858.CD005526.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005526.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005526.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(90)92630-Z","article-title":"Low dose cyclosporin versus placebo in patients with rheumatoid arthritis","volume":"335","author":"Tugwell","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD005526.pub2-BIB0055|cit55","first-page":"124","article-title":"A study of antimitochondrial antibodies in a random population in Estonia","volume":"92","author":"Turchany","year":"1997","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD005526.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/00042737-199908000-00001","article-title":"Prescribing habits in primary biliary cirrhosis: a national survey","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD005526.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD005526.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"Jounal of Hepatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005526.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:52:36Z","timestamp":1762858356000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005526.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005526.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,18]]}}}